Neural stem cell therapy for subacute and chronic ischemic stroke

Area of Science:

• Neuroscience
• Regenerative Medicine
• Cell Therapy

Background:

• Stroke is a leading cause of death and disability, often resulting from ischemia-reperfusion (IR) injury.
• Current treatments like tissue plasminogen activator (tPA) have limitations, with parenchymal tPA effects being harmful.
• Effective stroke therapies require multifactorial approaches targeting IR injury and promoting repair mechanisms.

Purpose of the Study:

• To review preclinical perspectives on neural stem cell (NSC) transplantation for neurovascular injury.
• To emphasize the potential of NSC therapy in the subacute and chronic phases of ischemic stroke.

Main Methods:

• Review of preclinical studies on neural stem cell transplantation.
• Focus on mechanisms relevant to stroke treatment, including IR injury, angiogenesis, and neurogenesis.

Main Results:

• NSCs offer a broad repertoire of therapeutic actions for neurovascular injury.
• Preclinical data suggest NSC transplantation is a promising strategy for stroke recovery.
• Therapeutic benefits are observed in both subacute and chronic stroke phases.

Conclusions:

• NSC transplantation represents a promising therapeutic avenue for ischemic stroke.
• Multifactorial treatment strategies, including cell-based therapies, are crucial for stroke recovery.
• Further preclinical research is warranted to optimize NSC therapy for clinical application.